Mumbai, April 12 -- Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Jaythari(R) (Deflazacort) Tablets, 6 mg, 18 mg, 30 mg, and 36 mg (USRLD: Emflaza (R) Tablets, 6 mg, 18 mg, 30 mg, and 36 mg).

Published by HT Digital Content Services with permission from Capital Market....